Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The challenges and molecular approaches surrounding interleukin-2-based therapeutics in cancer
2018
Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells
2017
Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
2019 StandoutNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017 Standout
Ferroptosis: molecular mechanisms and health implications
2020 Standout
The molecular hallmarks of epigenetic control
2016 Standout
Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action
2012
Phosphorylation of claudin-4 is required for tight junction formation in a human keratinocyte cell line
2008
Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo
2014
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Mechanisms and impacts of chromosomal translocations in cancers
2012
Long-Range Chromatin Interactions
2015
The Blood–Brain Barrier
2015 Standout
On the diagnosis of erythrodermic cutaneous T‐cell lymphoma
2006
Most Primary Cutaneous CD30-Positive Lymphoproliferative Disorders Have a CD4-Positive Cytotoxic T-Cell Phenotype
1997
The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids
2010
Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas
1999
The DSIF Subunits Spt4 and Spt5 Have Distinct Roles at Various Phases of Immunoglobulin Class Switch Recombination
2012 StandoutNobel
Altered claudin expression is a feature of chronic plaque psoriasis
2007
BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma
2010
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Role of AID in Tumorigenesis
2007 StandoutNobel
ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand Breaks
2010
Expression of nm23‐H1 is associated with poor prognosis in peripheral T‐cell lymphoma
2003
The Oslo definitions for coeliac disease and related terms
2012 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sezary syndrome
2005
Mycosis Fungoides and Sezary Syndrome
2017
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Psoriasis
2021 Standout
Tight junction-related structures in the absence of a lumen: Occludin, claudins and tight junction plaque proteins in densely packed cell formations of stratified epithelia and squamous cell carcinomas
2003
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
Merkel cell carcinoma
2017
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
2010
Celiac Disease
2007 Standout
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
2005 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy
2005
Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas
1998
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
2016 Standout
The DNA Damage Response: Making It Safe to Play with Knives
2010 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue
2001
Junctions gone bad: Claudins and loss of the barrier in cancer
2011
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Expression of Cytotoxic Proteins by Neoplastic T Cells in Mycosis Fungoides Increases with Progression from Plaque Stage to Tumor Stage Disease
1999
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
A novel method to assess collagen architecture in skin
2013
Oxidative Stress in Cancer
2020 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways
2012
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells
2005
Classification of cytotoxic T-cell and natural killer cell lymphomas
2003
Biology of Hodgkin's lymphoma
2002
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
2015
Expression of a mutated form of the p85α regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO)
2002
Up-Regulation of the Chemokine CCL18 by Macrophages Is a Potential Immunomodulatory Pathway in Cutaneous T-Cell Lymphoma
2011
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma
2016
Molecular biology of Hodgkin's lymphoma
2002
Cysteine Dioxygenase 1 Is a Tumor Suppressor Gene Silenced by Promoter Methylation in Multiple Human Cancers
2012
Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
2003
The Sézary syndrome: hematologic criteria
2003
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature
2004
Peripheral Blood T-Cell Clonality in Mycosis Fungoides and Nonlymphoma Controls
2003
The potential of proteasome inhibitors in cancer therapy
2008
Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
2000
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Mycosis fungoides and the Sézary syndrome
2004
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides
2006
Production of recombinant immunotherapeutics for anticancer treatment
2013
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans
2023 StandoutNobel
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Molecular Pathogenesis of Hodgkin's Lymphoma
2005
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
New and emerging HDAC inhibitors for cancer treatment
2014
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts
2012
Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB–Dependent Transcription and Induction of Apoptosis in CTCL
2011
SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile
2018
Surfaceome of classical Hodgkin and non‐Hodgkin lymphoma
2015
Epstein-Barr Virus Negative Clonal Plasma Cell Proliferations and Lymphomas in Peripheral T-cell Lymphomas
2007
Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome
2008
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas
2010
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Mechanisms that Promote and Suppress Chromosomal Translocations in Lymphocytes
2011
CutaneousT ‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
2015
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Diagnosing erythrodermic cutaneous T-cell lymphoma
2005
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
2018
Clonal heterogeneity in mycosis fungoides and its relationship to clinical course
2002
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
How I treat mycosis fungoides and Sézary syndrome
2016
Role of the Cldn6 Cytoplasmic Tail Domain in Membrane Targeting and Epidermal Differentiation In Vivo
2006
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?
2016
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Claudin-1, −2, −3, −4, −5, and −7 in Usual Interstitial Pneumonia and Sarcoidosis
2008
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Chalid Assaf being referenced
Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients With Cutaneous T-Cell Lymphoma
2010
Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma
2009
Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
2007
Loss of Proapoptotic Bcl-2-Related Multidomain Proteins in Primary Melanomas Is Associated with Poor Prognosis
2006
Maintenance therapy in cutaneous T-cell lymphoma: Who, when, what?
2007
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma:in vitroand phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition
2012
Clonal T cell receptor γ‐chain gene rearrangement by PCR‐based GeneScan analysis in the skin and blood of patients with parapsoriasis and early‐stage mycosis fungoides
2002
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
2012
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
2006
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
2017
Short German guidelines: Cutaneous lymphomas
2008
Clonal T-cell receptor ?-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation
1999
Tight junction proteins: a novel class of integral membrane proteins
2002
T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues
1999
The optimal use of bexarotene in cutaneous T-cell lymphoma
2007
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma
2009
Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease
2000
Vorinostat in combination with bexarotene in advanced cutaneous T-cell lymphoma: A phase I study
2009
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
2016
Intralesional cryosurgery enhances the involution of recalcitrant auricular keloids: a new clinical approach supported by experimental studies
2006
Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules
1996
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 9
2015
High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing
2000
Brief S2k guidelines – Merkel cell carcinoma
2013
Early TCR-β and TCR-γ PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications
2005